Cargando…
N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902876/ https://www.ncbi.nlm.nih.gov/pubmed/29661151 http://dx.doi.org/10.1186/s12872-018-0806-4 |
_version_ | 1783314832168058880 |
---|---|
author | Sterling, Madeline R. Durant, Raegan W. Bryan, Joanna Levitan, Emily B. Brown, Todd M. Khodneva, Yulia Glasser, Stephen P. Richman, Joshua S. Howard, George Cushman, Mary Safford, Monika M. |
author_facet | Sterling, Madeline R. Durant, Raegan W. Bryan, Joanna Levitan, Emily B. Brown, Todd M. Khodneva, Yulia Glasser, Stephen P. Richman, Joshua S. Howard, George Cushman, Mary Safford, Monika M. |
author_sort | Sterling, Madeline R. |
collection | PubMed |
description | BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. METHODS: The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF). RESULTS: Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event. CONCLUSION: NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0806-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5902876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59028762018-04-23 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study Sterling, Madeline R. Durant, Raegan W. Bryan, Joanna Levitan, Emily B. Brown, Todd M. Khodneva, Yulia Glasser, Stephen P. Richman, Joshua S. Howard, George Cushman, Mary Safford, Monika M. BMC Cardiovasc Disord Research Article BACKGROUND: N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. METHODS: The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF). RESULTS: Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event. CONCLUSION: NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0806-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902876/ /pubmed/29661151 http://dx.doi.org/10.1186/s12872-018-0806-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Sterling, Madeline R. Durant, Raegan W. Bryan, Joanna Levitan, Emily B. Brown, Todd M. Khodneva, Yulia Glasser, Stephen P. Richman, Joshua S. Howard, George Cushman, Mary Safford, Monika M. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title | N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title_full | N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title_fullStr | N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title_full_unstemmed | N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title_short | N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
title_sort | n-terminal pro-b-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902876/ https://www.ncbi.nlm.nih.gov/pubmed/29661151 http://dx.doi.org/10.1186/s12872-018-0806-4 |
work_keys_str_mv | AT sterlingmadeliner nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT durantraeganw nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT bryanjoanna nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT levitanemilyb nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT browntoddm nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT khodnevayulia nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT glasserstephenp nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT richmanjoshuas nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT howardgeorge nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT cushmanmary nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy AT saffordmonikam nterminalprobtypenatriureticpeptideandmicrosizemyocardialinfarctionriskinthereasonsforgeographicandracialdifferencesinstrokestudy |